What We're Reading: Page 327
Industry reads hand-picked by our editors
Apr 28, 2016
-
Bloomberg
Abbott to Buy St. Jude Medical in Deal Valued at About $25 Billion
-
Wall Street Journal
Vertex Pharmaceuticals’ Cystic Fibrosis Drug Disappoints
-
Reuters
Diabetes drug test results boost Novo Nordisk
-
The Street
Sarepta Can Win Speedy FDA Drug Approval
Apr 27, 2016
Apr 26, 2016
Apr 25, 2016
-
Washington Post
To sway drug approval, patient advocates turn up the heat on the FDA
-
NY Times
Theranos' Fate Rests With a Founder Who Answers Only to Herself
-
MIT Technology Review
We Still Haven’t Found a Fountain of Youth in Our DNA
Apr 22, 2016
Apr 21, 2016
-
Wall Street Journal
Glaxo Investors Want CEO Who Can Revitalize R&D
-
FierceBiotech
With Sarepta’s fate uncertain, BioMarin CEO Bienaimé weighs the future of Duchenne drug
-
Channel NewsAsia
HSA fast-tracking dengue vaccine evaluation
-
Reuters
Alere shares sink after Abbott CEO fuels speculation deal at risk
Previous
